Received Feb 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
missed a dose of TWINRIX as they never followed up for next dose; This non-serious case was reported by a pharmacist via other manufacturer and described the occurrence of incomplete course of vaccination in a patient who did not receive HAB (Twinrix) for prophylaxis. The patient did not receive Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient had incomplete course of vaccination (Verbatim: missed a dose of TWINRIX as they never followed up for next dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 05-FEB-2026 The batch number was not provided upon follow up with the reporter.